The Latin America hemodynamic monitoring market size is anticipated to expand at a significant CAGR during the forecast period, 2021-2028. The growth of the market is attributed to increasing number of critically ill geriatric cases.
Hemodynamic is a branch of physiology that deals with measuring the blood flow and oxygenation of blood within the cardiovascular system. The main objective of hemodynamic monitoring is to maintain adequate tissue perfusion. The most common types of hemodynamic monitors are ECG monitoring, central venous pressure, kidney function, pulse oximetry, arterial pressure monitoring, pulmonary artery catheter, and transesophageal echocardiography. Indications for hemodynamic monitoring includes the requirement to assess left ventricular function, to estimate patient prognosis and to monitor cardiac performance.
The hemodynamic monitoring devices market was negatively impacted during the first half of 2020 due to COVID-19 pandemic. This, in turn, was due to stringent lockdowns that decreased the patient volume in hospitals due to rescheduling and delaying of procedures.
Market Trends, Drivers, Restraints and Opportunities
- Rising prevalence of cardiac disorders and diabetes is projected to drive the market growth during the forecast period.
- Increasing demand for home-based and non-invasive monitoring systems are expected to boost the market growth in the coming years.
- Growing advancement in technology due to intensive funding by private players and government bodies are anticipated to drive the market growth during the forecast period.
- Increasing number of people suffering from hypertension is projected to drive the market growth during the forecast period.
- Rising research into hemodynamic monitoring systems are expected to boost the market growth in the coming years.
- Growing number of surgeries is anticipated to drive the market growth during the forecast period.
- Rising awareness initiatives by industry players and government focus on critical care infrastructure & services are projected to foster the market growth.
- Expanding demand for patient monitoring devices in non-hospital settings and emerging economies is expected to fuel the market growth.
- Increasing pricing pressure on market players are anticipated to drive the market growth during the forecast period.
- Rising patient awareness related to disease diagnosis and dearth of skilled professionals are adversely impacting the growth of the market is projected to drive the market growth during the forecast period.
- High risk associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis is expected to restrain the growth of this market.
- Booming healthcare sector in emerging economies are key opportunities for emerging players during the forecast period.
Scope of Hemodynamic Monitoring Market Report
The report on the Latin America probiotics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Hemodynamic Monitoring Market - Latin America Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Systems (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, Non-invasive Monitoring Systems) and Applications (Laboratory-based Monitoring Systems, Home-based Monitoring Systems, and Hospital-based Monitoring Systems)
|
|
Geographical Scope
|
Brazil, Argentina, and Rest of Latin America
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Getinge Group; Koninklijke Philips NV; Edwards Life Sciences Corporation; ICU Medical Inc.; and GE Healthcare
|
Latin America Hemodynamic Monitoring Market Segment Insights
Non-invasive monitoring systems segment to hold a significant market share
On the basis of systems, the market is divided into minimally invasive monitoring systems, invasive monitoring systems, and non-invasive monitoring systems. The minimally invasive monitoring systems segment is expected to hold a key share of the market in the coming years. This type of monitoring system provides valuable information regarding the overall cardiovascular status of the patient. Moreover, declining cardiac index in trauma patients can indicate the requirement for revaluation of the patient. However, the non-invasive monitoring systems segment is anticipated to expand at a rapid pace during the forecast period owing to reduction of staffing costs, treatment expenses, and hospital stay, rising incidence of respiratory disorders, fewer complications of noninvasive hemodynamic monitoring as compared to invasive methods, better portability, ease of use, and better precision.
Hospital-based monitoring systems segment is expected to grow at a rapid pace
Based on applications, the market is segregated into laboratory-based monitoring systems, home-based monitoring systems, and hospital-based monitoring systems. The laboratory-based monitoring systems segment is anticipated to hold a key share of the market in the coming years. Hemodynamic monitoring collect and collate data from connected devices without human assistance. On the other hand, the hospital-based monitoring systems segment is anticipated to expand at a rapid pace during the forecast period owing to ease of access to patient data, the ability to deliver higher-quality care to more patients with a lower risk of burnout.
Argentina is estimated to account a major market share
In terms of geography, the market is classified as Brazil, Argentina, and Rest of Latin America. Brazil is expected to constitute a key share of the market during the projected period due to increasing number of clinics, hospitals, and individually operating physicians adopting these devices. However, the market in Argentina is anticipated to expand at a rapid pace during the forecast period due to growing healthcare industry and extensive government reimbursement coverage for critical cardiac procedures.
Segments
The Latin America hemodynamic monitoring market has been segmented on the basis of
Systems
- Minimally Invasive Monitoring Systems
- Invasive Monitoring Systems
- Non-invasive Monitoring Systems
Applications
- Laboratory-based Monitoring Systems
- Home-based Monitoring Systems
- Hospital-based Monitoring Systems
Geography
- Brazil
- Argentina
- Rest of Latin America
Key Players
Competitive Landscape
Key players competing in the Latin America hemodynamic monitoring market includes Nestle SA; Groupe Danone; PepsiCo Inc.; Kevita Inc.; Fonterra Cooperative Group; Yakult Honsha Co Ltd.
Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.
Request For Customization
Enquiry Before Buying
Speak With Analyst
